Effect of Obesity on Clinical Failure of Patients Treated With β-Lactams.

Nathan A PinnerNatalie G TapleyKatie E Barber Kayla R Stover Jamie L Wagner

Published in: Open forum infectious diseases (2021)

Obese patients treated with β-lactams have higher rates of treatment failure and longer hospitalization periods than nonobese patients. Future studies are needed to assess the impact of therapeutic drug monitoring and specific dosing recommendations for targeted infection types.

Keyphrases

metabolic syndrome
weight loss
end stage renal disease
type diabetes
ejection fraction
newly diagnosed
insulin resistance
prognostic factors
peritoneal dialysis
bariatric surgery
weight gain
clinical practice
patient reported outcomes
physical activity
skeletal muscle
body mass index
drug delivery
smoking cessation